Cyclosporin A combined with vincristine, doxorubicine and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914)

Pieter Sonneveld; S Suciu; P Weijermans; M Beksac; R Nieuwirtova; G Solbu; HM Lokhorst; J van der Lelie; H Dohner; H Gerhartz; CM Segeren; R Willemze; Bob Löwenberg

doi:10.1046/j.1365-2141.2001.03171.x

Cyclosporin A combined with vincristine, doxorubicine and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914)

Pieter Sonneveld, S Suciu, P Weijermans, M Beksac, R Nieuwirtova, G Solbu, HM Lokhorst, J van der Lelie, H Dohner, H Gerhartz, CM Segeren, R Willemze, Bob Löwenberg

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

89 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	895-902
Number of pages	8
Journal	British Journal of Haematology
Volume	115
DOIs	https://doi.org/10.1046/j.1365-2141.2001.03171.x
Publication status	Published - 2001

Research programs

EMC MM-02-41-03

Access to Document

10.1046/j.1365-2141.2001.03171.x

http://hdl.handle.net/1765/64854

Cite this

Sonneveld, P., Suciu, S., Weijermans, P., Beksac, M., Nieuwirtova, R., Solbu, G., Lokhorst, HM., van der Lelie, J., Dohner, H., Gerhartz, H., Segeren, CM., Willemze, R., & Löwenberg, B. (2001). Cyclosporin A combined with vincristine, doxorubicine and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914). British Journal of Haematology, 115, 895-902. https://doi.org/10.1046/j.1365-2141.2001.03171.x

@article{c182c8b2087b4f7a95c706fba2c335ad,

title = "Cyclosporin A combined with vincristine, doxorubicine and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914)",

author = "Pieter Sonneveld and S Suciu and P Weijermans and M Beksac and R Nieuwirtova and G Solbu and HM Lokhorst and {van der Lelie}, J and H Dohner and H Gerhartz and CM Segeren and R Willemze and Bob L{\"o}wenberg",

year = "2001",

doi = "10.1046/j.1365-2141.2001.03171.x",

language = "Undefined/Unknown",

volume = "115",

pages = "895--902",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley & Sons Inc.",

}

Sonneveld, P, Suciu, S, Weijermans, P, Beksac, M, Nieuwirtova, R, Solbu, G, Lokhorst, HM, van der Lelie, J, Dohner, H, Gerhartz, H, Segeren, CM, Willemze, R & Löwenberg, B 2001, 'Cyclosporin A combined with vincristine, doxorubicine and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914)', British Journal of Haematology, vol. 115, pp. 895-902. https://doi.org/10.1046/j.1365-2141.2001.03171.x

Cyclosporin A combined with vincristine, doxorubicine and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914). / Sonneveld, Pieter; Suciu, S; Weijermans, P et al.
In: British Journal of Haematology, Vol. 115, 2001, p. 895-902.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Cyclosporin A combined with vincristine, doxorubicine and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914)

AU - Sonneveld, Pieter

AU - Suciu, S

AU - Weijermans, P

AU - Beksac, M

AU - Nieuwirtova, R

AU - Solbu, G

AU - Lokhorst, HM

AU - van der Lelie, J

AU - Dohner, H

AU - Gerhartz, H

AU - Segeren, CM

AU - Willemze, R

AU - Löwenberg, Bob

PY - 2001

Y1 - 2001

U2 - 10.1046/j.1365-2141.2001.03171.x

DO - 10.1046/j.1365-2141.2001.03171.x

M3 - Article

SN - 0007-1048

VL - 115

SP - 895

EP - 902

JO - British Journal of Haematology

JF - British Journal of Haematology

ER -

Sonneveld P, Suciu S, Weijermans P, Beksac M, Nieuwirtova R, Solbu G et al. Cyclosporin A combined with vincristine, doxorubicine and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914). British Journal of Haematology. 2001;115:895-902. doi: 10.1046/j.1365-2141.2001.03171.x